A Durham company is pushing back on media reports questioning the safety of its lead product as the firm begins its ...

At this year’s ABRF Annual Meeting (23–26 March; NV, USA), biotech companies had the opportunity to showcase their technology ...

Radiopharm Theranostics Limited targets oncology with radiotherapeutics like Lu-RAD204 for NSCLC. Key 2025 data signals ...

From Phil King’s Regal Partners to Russel Pillemer’s Pengana Capital, fund managers loved vision treatment hopeful Opthea.

Session Date and Time: Monday, April 28, 2:00 - 5:00 p.m.

A fresh wave of layoffs jolted the Bay Area during March with several rounds of cutbacks that erased well over 600 jobs.

Zhejiang Langhua Pharmaceutical Co., Ltd. ("Langhua Pharmaceutical"), a wholly-owned subsidiary of Viva Biotech Holdings ("Viva Biotech"), underwent a cGMP (Current Good Manufacturing Practices) ...

JP Morgan sees strong growth for Ascentage Pharma, citing its late-stage cancer drugs. The biotech's 2024 sales surged 342% ...

His areas of experience include handling complex quality control operations, regulatory compliance, and leadership of large ...

We recently published a list of 15 Cheapest Stocks Insiders Are Buying In March. In this article, we are going to take a look ...

RNA-based therapeutics are gaining traction due to advancements in delivery technologies, despite historical challenges with ...

Alcon has acquired a majority interest in Aurion Biotech, according to a press release. Aurion will operate as a separate ...